These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 11724293

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T, Uramoto H, Oyama T, Yashima Y, Gu C, Morita M, Sugio K, Kohno K, Yasumoto K.
    Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D, Huang CL, Kameyama K, Hayashi E, Yamauchi A, Sumitomo S, Yokomise H.
    Cancer; 2002 Apr 15; 94(8):2239-47. PubMed ID: 12001123
    [Abstract] [Full Text] [Related]

  • 5. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
    Oda Y, Sakamoto A, Shinohara N, Ohga T, Uchiumi T, Kohno K, Tsuneyoshi M, Kuwano M, Iwamoto Y.
    Clin Cancer Res; 1998 Sep 15; 4(9):2273-7. PubMed ID: 9748149
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
    Magan N, Szremska AP, Isaacs RJ, Stowell KM.
    Biochem J; 2003 Sep 15; 374(Pt 3):723-9. PubMed ID: 12769819
    [Abstract] [Full Text] [Related]

  • 9. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
    Hopfner R, Mousli M, Jeltsch JM, Voulgaris A, Lutz Y, Marin C, Bellocq JP, Oudet P, Bronner C.
    Cancer Res; 2000 Jan 01; 60(1):121-8. PubMed ID: 10646863
    [Abstract] [Full Text] [Related]

  • 10. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
    Giménez-Bonafé P, Fedoruk MN, Whitmore TG, Akbari M, Ralph JL, Ettinger S, Gleave ME, Nelson CC.
    Prostate; 2004 May 15; 59(3):337-49. PubMed ID: 15042610
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
    Miracco C, Maellaro E, Pacenti L, Del Bello B, Valentini MA, Rubegni P, Pirtoli L, Volpi C, Santopietro R, Tosi P.
    Int J Oncol; 2003 Jul 15; 23(1):213-20. PubMed ID: 12792796
    [Abstract] [Full Text] [Related]

  • 12. Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?
    Kimura F, Kawamura J, Watanabe J, Kamoshida S, Kawai K, Okayasu I, Kuwao S.
    Diagn Cytopathol; 2010 Mar 15; 38(3):161-7. PubMed ID: 19821496
    [Abstract] [Full Text] [Related]

  • 13. DNA topoisomerase IIalpha and -beta expression in human ovarian cancer.
    Withoff S, van der Zee AG, de Jong S, Hollema H, Smit EF, Mulder NH, de Vries EG.
    Br J Cancer; 1999 Feb 15; 79(5-6):748-53. PubMed ID: 10070864
    [Abstract] [Full Text] [Related]

  • 14. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
    Fujita T, Ito K, Izumi H, Kimura M, Sano M, Nakagomi H, Maeno K, Hama Y, Shingu K, Tsuchiya S, Kohno K, Fujimori M.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8837-44. PubMed ID: 16361573
    [Abstract] [Full Text] [Related]

  • 15. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
    Ohga T, Koike K, Ono M, Makino Y, Itagaki Y, Tanimoto M, Kuwano M, Kohno K.
    Cancer Res; 1996 Sep 15; 56(18):4224-8. PubMed ID: 8797596
    [Abstract] [Full Text] [Related]

  • 16. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y.
    Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420
    [Abstract] [Full Text] [Related]

  • 17. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S, Kovacs K, Horvath E, Rotondo F, Kuroki T, Lloyd RV, Scheithauer BW.
    Mod Pathol; 2002 Nov 18; 15(11):1205-12. PubMed ID: 12429800
    [Abstract] [Full Text] [Related]

  • 18. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.
    Yahata H, Kobayashi H, Kamura T, Amada S, Hirakawa T, Kohno K, Kuwano M, Nakano H.
    J Cancer Res Clin Oncol; 2002 Nov 18; 128(11):621-6. PubMed ID: 12458343
    [Abstract] [Full Text] [Related]

  • 19. Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response.
    Guinee DG, Holden JA, Benfield JR, Woodward ML, Przygodzki RM, Fishback NF, Koss MN, Travis WD.
    Cancer; 1996 Aug 15; 78(4):729-35. PubMed ID: 8756364
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
    Mattila R, Alanen K, Syrjänen S.
    Arch Dermatol Res; 2007 Jan 15; 298(8):381-8. PubMed ID: 17072627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.